Non-Small Cell Lung Cancer Patients Harboring HER2 Mutations: Clinical Characteristics and Management in a Real-Life Setting. Cohort HER2 EXPLORE GFPC 02–14

被引：0
|
作者：
Jean-Bernard Auliac
Pascal Dô
Sophie Bayle
Hélène Doubre
Florent Vinas
Jacques Letreut
Lionel Falchero
Pierre Alexandre Hauss
Pascal Thomas
Christos Chouaid
机构：
[1] Hopital de Mantes La Jolie,Chest Department
[2] Centre Francois Baclesse,Oncolgy Department
[3] Chest Department,Chest Department
[4] Institut de Cancérologie,Chest Department
[5] Hôpital Foch,Chest Department
[6] Centre Hospitalier Intercommunal de Créteil,Chest Department
[7] Hopital d’Aix-en-Provence,Chest Department
[8] Hopital de Villefranche,Chest Department
[9] Hopital D’Elbeuf,undefined
[10] Hopital de Gap,undefined
来源：
Advances in Therapy | 2019年 / 36卷
关键词：
mutation; Lung adenocarcinoma; Management; Prognosis; Target therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2161 / 2166
页数：5
相关论文
共 50 条
  • [1] Non-Small Cell Lung Cancer Patients Harboring HER2 Mutations: Clinical Characteristics and Management in a Real-Life Setting. Cohort HER2 EXPLORE GFPC 02-14
    Auliac, Jean-Bernard
    Do, Pascal
    Bayle, Sophie
    Doubre, Helene
    Vinas, Florent
    Letreut, Jacques
    Falchero, Lionel
    Hauss, Pierre Alexandre
    Thomas, Pascal
    Chouaid, Christos
    ADVANCES IN THERAPY, 2019, 36 (08) : 2161 - 2166
  • [2] NSCLC Patients Harboring HER2 Mutation: Clinical Characteristics and Management in Real World Setting. EXPLORE GFPC 02-14
    Auliac, Jean Bernard
    Do, Pascal
    Bayle, Sophie
    Doubre, Helene
    Vinas, Florent
    Letreut, Jacques
    Fraboulet, Gislaine
    Falchero, Lionel
    Thomas, Pascal
    Chouaid, Christos
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1271 - S1271
  • [3] Non small cell lung cancer (NSCLC) patients harboring BRAF mutation: Clinical characteristics and management in real world setting. Cohort BRAF EXPLORE GFPC 02-14
    Auliac, J. B.
    Bayle, S.
    Vergnenegre, A.
    Fraboulet, G.
    Lecaer, H.
    Falchero, L.
    Do, P.
    Doubre, H.
    Hauss, P. A.
    Vinas, A.
    Larive, S.
    Chiappa, A. M.
    Marin, B.
    Chouaid, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Molecular Characteristics of HER2 Mutations in Non-Small Cell Lung Cancer
    Wei, X.
    Gao, X.
    Zhang, X.
    Chen, Z.
    Wu, Y.
    Zhou, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S848 - S849
  • [5] HER2 mutations in Chinese patients with non-small cell lung cancer
    Song, Zhengbo
    Yu, Xinmin
    Shi, Zhiyong
    Zhao, Jun
    Zhang, Yiping
    ONCOTARGET, 2016, 7 (47) : 78152 - 78158
  • [6] HER2 Mutations in Chinese Patients with Non-Small Cell Lung Cancer
    Song, Zhengbo
    Zhang, Yiping
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S494 - S495
  • [7] Progress in Treatment of Non-Small Cell Lung Cancer Harboring HER2 Aberrations
    Ni, Jun
    Zhang, Li
    ONCOTARGETS AND THERAPY, 2021, 14 : 4087 - 4098
  • [8] Clinicopathologic Characteristics of Patients with HER2 Insertions in Non-small Cell Lung Cancer
    Shi Bu
    Rui Wang
    Yunjian Pan
    Su Yu
    Xuxia Shen
    Yuan Li
    Yihua Sun
    Haiquan Chen
    Annals of Surgical Oncology, 2017, 24 : 291 - 297
  • [9] Clinicopathologic Characteristics of Patients with HER2 Insertions in Non-small Cell Lung Cancer
    Bu, Shi
    Wang, Rui
    Pan, Yunjian
    Yu, Su
    Shen, Xuxia
    Li, Yuan
    Sun, Yihua
    Chen, Haiquan
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (01) : 291 - 297
  • [10] Clinical Characteristics and Prognosis of HER2 Gene Phenotype in Patients with Non-Small Cell Lung Cancer
    Diao, Wei-Ying
    Ding, Cheng-Long
    Yuan, Bo-Yang
    Li, Zan
    Sun, Na
    Huang, Jia-Bin
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 9153 - 9161
12345